Gilead Sciences | GILD - نسبة السعر إلى الأرباح

سعر السهم
130.45
التغيير اليومي
0.87 0.67%
شهريا
-3.99%
سنويا
22.88%
Q2 التوقعات
126.98




Pe تغيير تاريخ
AbbVie 23.03 1 2026-03
Agios Pharmaceuticals 3.56 0 2026-03
ALKERMES 39.33 19.8 2026-03
Alnylam Pharmaceuticals 80.04 90.66 2026-03
Amgen 19.84 5.47 2026-03
Biogen 13.7 0.32 2026-03
BioMarin Pharmaceutical 15.28 3.96 2026-03
Bristol-Myers Squibb 9.08 0.2 2026-03
Eli Lilly 40.27 0.06 2026-03
Gilead Sciences 17.7 2.07 2026-03
GlaxoSmithKline 14.87 3.72 2026-03
Glaxosmithkline 11.66 0.28 2025-12
Incyte 15.35 0.51 2026-03
J&J 24.53 0.91 2026-03
Merck 16.52 2.6 2026-03
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 28.09 807.38 2026-03
Novartis 20.17 2.32 2026-03
Pfizer 9.32 5.16 2026-03
PTC Therapeutics 9.98 3.25 2025-12
Puma Biotechnology 13.93 44.88 2024-06
Regeneron Pharmaceuticals 25.14 7.03 2026-03
Sanofi 11.84 0.14 2026-03
Sarepta Therapeutics 27.27 0 2025-12
United Therapeutics 20.42 3.1 2026-03
Vertex Pharmaceuticals 25.82 0.33 2026-03